Phase I, multicenter, dose-escalation study of avadomide in adult Japanese patients with advanced malignancies.
- DOI
- 10.1111/cas.14704
- Published
- 2021 Jan
- Container
- Cancer science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/cas.14704,
title = {Phase I, multicenter, dose-escalation study of avadomide in adult Japanese patients with advanced malignancies.},
author = {Hatake K and Chou T and Doi T and Terui Y and Kato H and Hirose T and Seo S and Pourdehnad M and Ogaki Y and Fujimoto H and Hagner PR and Yamamoto K},
year = {2021},
journal = {Cancer science},
doi = {10.1111/cas.14704},
url = {https://doi.org/10.1111/cas.14704}
}RIS
TY - JOUR TI - Phase I, multicenter, dose-escalation study of avadomide in adult Japanese patients with advanced malignancies. AU - Hatake K AU - Chou T AU - Doi T AU - Terui Y AU - Kato H AU - Hirose T AU - Seo S AU - Pourdehnad M AU - Ogaki Y AU - Fujimoto H AU - Hagner PR AU - Yamamoto K PY - 2021 JO - Cancer science DO - 10.1111/cas.14704 UR - https://doi.org/10.1111/cas.14704 ER -
APA
K, H., T, C., T, D., Y, T., H, K., T, H., S, S., M, P., Y, O., H, F., PR, H., & K, Y. (2021). Phase I, multicenter, dose-escalation study of avadomide in adult Japanese patients with advanced malignancies.. Cancer science. https://doi.org/10.1111/cas.14704
Source records
- pubmed · retrieved 2026-09-26T03:00:28.194Z